Trial of colonic stenting for large bowel obstruction

Interventions: This study will compare the outcomes of colorectal surgery (bowel resection and possible stoma formation) versus colonic stent insertion using Ultraflex or Wallfex Precision Colonic Stent manufactured by Boston Scientific (TGA approved in Australia) to determine optimal management of non-curable colorectal cancer. Comparisons will be made between quality of life, length of stay, complications and cost to identify which group has the optimal outcome. The study will be conducted over 3 years. Primary outcome(s): To compare quality of life between surgical intervention and colonic stent insertion in the first 12 months following the procedure.[Daily until discharge from hospital, then at 1, 2, and 4 weeks and 3, 6 and 12 months] Study Design: Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Factorial;Type of endpoint: Efficacy